Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 196 M204 M163 M141 M202 M 710 M Research & development ————— — Operating income 221 M193 M234 M156 M19 M 602 M Non-Operating Income, Total -1 M-1 M0-1 M0 -2 M Interest expense, net of interest capitalized 51 M53 M53 M63 M64 M 233 M Non-Operating Income, excl. Interest Expenses -52 M-54 M-53 M-64 M-64 M -235 M Unusual income/expense ————— — Pretax income 170 M139 M181 M92 M-45 M 367 M Equity in earnings ——1 M0— — Taxes 43 M35 M40 M21 M-2 M 94 M Non-controlling/minority interest ————— — After tax other income/expense -6 M19 M-3 M26 M5 M 47 M Net income before discontinued operations 127 M104 M142 M71 M-43 M 274 M Discontinued operations ————— — Net income 127 M104 M142 M71 M-43 M 274 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 127 M104 M142 M71 M-43 M 274 M Basic earnings per share (Basic EPS) 0.420.350.480.23-0.14 0.92 Diluted earnings per share (Diluted EPS) 0.420.340.480.24-0.14 0.92 Average basic shares outstanding 302.2 M301.2 M297.1 M299.3 M296.7 M — Diluted shares outstanding 303.2 M301.6 M297.6 M299.8 M296.7 M — EBITDA 366 M333 M376 M316 M119 M 1.14 B EBIT 235 M203 M250 M167 M-20 M 600 M Cost of revenue 1.68 B1.78 B1.76 B1.8 B1.85 B 7.19 B Other cost of goods sold 1.68 B1.78 B1.76 B1.8 B1.85 B 7.19 B Depreciation & amortization (cash flow) 131 M130 M126 M149 M139 M 544 M